DDInter1782 DDInter875
Tetracosactide (also known as Cosyntropin) is a synthetic peptide that is identical to the 24-amino acid segment (sequence: SYSMEHFRWGKPVGKKRRPVKVYP) at the N-terminal of adrenocorticotropic hormone. ACTH (1-24), a segment similar in all species, contains the biological activity that stimulates production of corticosteroids in the adrenal cortex. Tetracosactide exhibits the same activity as natural ACTH with regard to all its biological activities. The complex results in a product whose absorption in man is effected over a longer period of time as compared to corticotropin. Therefore, therapy may be maintained with less frequent administration.
Human papillomavirus type 11 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) types 6, 11, 16 and 18. The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, and 18, which are produced by separate fermentations in recombinant *Saccharomyces cerevisiae* and self-assembled into VLPs.
Tetracosactide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Racepinephrine
Tetracosactide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Salmeterol
Tetracosactide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Pentobarbital
Tetracosactide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Ustekinumab
Tetracosactide {u} may lead to a major life threatening interaction when taken with {v} Etanercept
Tetracosactide {u} may lead to a major life threatening interaction when taken with {v} Fingolimod
Tetracosactide may cause a minor interaction that can limit clinical effects when taken with Racepinephrine
Tetracosactide may cause a minor interaction that can limit clinical effects when taken with Salmeterol
Tetracosactide may cause a moderate interaction that could exacerbate diseases when taken with Pentobarbital
Tetracosactide may cause a moderate interaction that could exacerbate diseases when taken with Ustekinumab
Tetracosactide may lead to a major life threatening interaction when taken with Etanercept
Tetracosactide may lead to a major life threatening interaction when taken with Fingolimod